Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Antwerp
Clinical trial register · Belgium

Clinical Trials in Antwerp, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3055 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
3055
Studies in scope
all four open statuses
1723
Recruiting now
open to new participants
505
Lead sponsors
across recruiting studies
Top sites
Leuven 1275 Brussels 1118 Ghent 1030 Liège 562 Edegem 441
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Universitaire Ziekenhuizen KU Leuven17 Janssen Research & Development, LLC17 University Hospital, Antwerp16 Universiteit Antwerpen12 Stichting Hemato-Oncologie voor Volwassenen Nederland10 European Organisation for Research and Treatment of Cancer - EORTC7 Eli Lilly and Company5 Regeneron Pharmaceuticals5 University Ghent5 Bayer4 ViiV Healthcare4 AstraZeneca4 Novartis Pharmaceuticals4 University Hospital, Ghent4 Institute of Tropical Medicine, Belgium4 Merck Sharp & Dohme LLC3 Universitair Ziekenhuis Brussel3 Acerta Pharma BV3 Genzyme, a Sanofi Company3 AZ Sint-Jan AV3 Takeda3 Erasme University Hospital2 Celgene2 Jules Bordet Institute2 University of Liege2 Show all 153
Site location
Leuven1275 Brussels1118 Ghent1030 Liège562 Edegem441 Antwerp290 Bruges263 Roeselare249 Hasselt215 Aalst185 Kortrijk183 Charleroi175 Genk174 Anderlecht167 Yvoir153 Namur138 Jette128 Sint-Niklaas116 Bonheiden101 Wilrijk75 Brasschaat72 Mechelen61 La Louvière59 Woluwe-Saint-Lambert57 Ottignies48 Show all 205
All 205 locations
Target enrolment
to

Trials with a site in Antwerp

290 of 3055 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Recruiting
University Ghent
Not applicable
183
Antwerp, Ghent
2026-11-04
Not yet open
Belgo-Luxembourg Leadless PM Registry
NCT07879716Bradyarrhythmias, AV Block Complete, AV Block-2Nd Degree-Type 1, Pacemaker
Universitaire Ziekenhuizen KU Leuven
Not applicable
190
Leuven, Antwerp, Brussels, Ghent, Liège, Roeselare
2026-11-01
Not yet open
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
NCT07782112Prostatic Neoplasms, Biochemical Recurrence, Oligometastatic Prostate Cancer
DrugEnzalutamide
Ente Ospedaliero Cantonale, Bellinzona
Phase 3
140
Aalst, Antwerp, Bruges, Brussels, Hasselt, Kortrijk, Mechelen
2026-11
Not yet open
A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer
NCT07711067Pancreatic Ductal Adenocarcinoma (mPDAC), Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
ElmediX
Phase 2/3
95
Antwerp, Ghent
2026-10-01
Not yet open
Mi2000 TICI Follow-up
NCT07902414Hearing Loss, Binaural, Cochlear Implantation
MED-EL Elektromedizinische Geräte GmbH
Observational
36
Antwerp, Liège
2026-10
Recruiting
Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus
NCT07559188Keratoconus, Presbyopia, Scleral Contact Lenses, Pinhole
Azalea Vision
Not applicable
16
Antwerp
2026-09-28
Recruiting
Morrow Eyewear
Not applicable
50
Antwerp, Mechelen
2026-09-24
Recruiting
Takeda
Phase 3
324
La Louvière, Leuven, Roeselare, Antwerp, Yvoir
2026-09-10
Not yet open
PRotEin Provision in Critical IllneSs -2
NCT07529522Critical Illness, Intensive Care (ICU)
Ziekenhuis Oost-Limburg
Not applicable
1,026
Antwerp, Genk, Ghent, Hasselt, Jette, Kortrijk, Leuven, Liège
2026-09
Recruiting
Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants
NCT07636551Yellow Fever (Healthy Volunteers), Biopsy/Methods
Institute of Tropical Medicine, Belgium
Not applicable
40
Antwerp
2026-08-10
Recruiting
Medtronic MiniMed, Inc.
Not applicable
116
Antwerp, Brussels, Leuven
2026-07-19
Recruiting
Universitaire Ziekenhuizen KU Leuven
Observational
1,600
Antwerp, Brussels, Ghent, Leuven, Liège
2026-07
Recruiting
University Hospital, Antwerp
Observational
270
Antwerp
2026-06-10
Recruiting
Vrije Universiteit Brussel
Phase 2
120
Antwerp, Brussels, Leuven
2026-06-05
Not yet open
Institute of Tropical Medicine, Belgium
Phase 3
561
Antwerp, Brussels, Ghent, Jette, Liège, Neder-Over-Heembeek
2026-05-15
Recruiting
Developing and Testing a Preventive Primary Care Parenting Intervention to Strengthen Parent-Infant Co-Regulation in Families Experiencing Early Regulatory Difficulties
NCT07541716Infant Regulatory Problems, Regulatory Problems in Infancy, Parental Stress, Parental Self-efficacy
Universiteit Antwerpen
Not applicable
200
Antwerp
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
531
Antwerp, Bruges, Brussels, Edegem, Ghent, Leuven, Liège, Roeselare
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
342
Antwerp, Bruges, Brussels, Edegem, Ghent, Leuven, Liège, Roeselare
2026-04-29
Recruiting
Ole Hyldegaard
Phase 4
1,480
Antwerp
2026-04-04
Recruiting
Universiteit Antwerpen
Phase 2
50
Antwerp, Ghent, Leuven
2026-03-25
Recruiting
R³ Rehab Pathway Versus Usual Care After Lumbar Radicular Surgery
NCT07313566Lumbar Radiculopathy, Radicular Low Back Pain
Universitaire Ziekenhuizen KU Leuven
Not applicable
480
Antwerp, Bruges, Brussels, Charleroi, Geel, Genk, Hasselt, Herentals
2026-03-16
Recruiting
University Hospital of Leuven Leuven
Not applicable
100
Antwerp, Genk, Hasselt, Leuven
2026-03-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Antwerp, Bruges, Brussels, Charleroi, Geel, Ghent, Hasselt, Jolimont
2026-03-01
Recruiting
ViiV Healthcare
Phase 2
186
Antwerp, Brussels, Ghent
2026-02-11
Recruiting
Universitaire Ziekenhuizen KU Leuven
Phase 2
356
Antwerp, Brussels, Ghent, Hasselt, Kortrijk, Leuven, Liège, Namur
2026-02-01
Not yet open
Institute of Tropical Medicine, Belgium
Observational
95
Antwerp
2026-01-15
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Aalst, Antwerp, Ghent, La Louvière, Liège
2025-12-19
Recruiting
Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer
NCT06962137Gastric Cancer Adenocarcinoma Metastatic, Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
DrugZolbetuximab
Universitaire Ziekenhuizen KU Leuven
Phase 2
100
Antwerp, Brussels, Ghent, Leuven, Roeselare
2025-12-11
Recruiting
Universiteit Antwerpen
Observational
73
Antwerp
2025-12-10
Recruiting
AstraZeneca
Phase 3
420
Antwerp, Brussels, Ghent, Leuven, Roeselare, Yvoir
2025-11-11
Recruiting
European STXBP1 Consortium
Observational
120
Antwerp
2025-11-04
Recruiting
The Belgian Society of Medical Oncology
Observational
550
Anderlecht, Antwerp, Bonheiden, Brasschaat, Edegem, Ghent, Gilly, Hasselt
2025-10-22
Recruiting
CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS
NCT07189091Critical Care, Intensive Care, Fluid Accumulation, Fluid and Electrolyte Imbalance, Critical Illness
University Hospital, Antwerp
Phase 4
640
Antwerp, Edegem, Merksem
2025-10-07
Recruiting
Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening
NCT07631624Epigenetics, DNA Methylation, Lung Cancer Screening, Risk Stratification With Biomarker
University Hospital, Antwerp
Not applicable
1,000
Antwerp
2025-10-04
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Brussels, Jette, Waterschei-Zwartberg, Aalst, Sint-Gillis-Dendermonde, Antwerp, Bruges, Genk
2025-10-02
Recruiting
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
NCT07040774Genetic Disease, Immune Dysfunction, Neurological Diseases or Conditions, Autoimmune Diseases
Imagine Institute
Observational
500
Antwerp
2025-10-01
Recruiting
AZ Sint-Jan AV
Observational
100
Antwerp, Bruges, Brussels, Ghent, Liège
2025-09-25
Recruiting
A Study to Evaluate the Safety and Performance of a Vestibular Implant in Adults to Provide Balance Restoration
NCT06805175Vestibulopathy, Moderate to Severe Hearing Loss, Normal Hearing, Balance Deficits
Cochlear
Not applicable
18
Antwerp
2025-09-18
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Aalst, Alken, Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Edegem
2025-09-02
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Antwerp, Brussels, Ghent, Jette, Leuven, Libramont, Liège, Namur
2025-08-26
Recruiting
Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
NCT07080476Breast Edema, Breast Cancer Related Lymphoedema, Breast Cancer Related Lymphedema, Truncal Lymphedema
Universiteit Antwerpen
Not applicable
128
Antwerp, Ghent, Kortrijk
2025-08-25
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Antwerp, Brussels, Ghent, Leuven, Liège, Yvoir
2025-08-05
Recruiting
University Ghent
Not applicable
129
Antwerp, Ghent
2025-07-03
Recruiting
University Hospital, Antwerp
Observational
400
Antwerp
2025-06-30
Recruiting
University Hospital, Antwerp
Not applicable
20
Antwerp
2025-06-26
Not yet open
Assessment and Treat Neglect Patients With a VR Application
NCT06999473Neglect, Hemispatial, Stroke, Virtual Reality Therapy
Universiteit Antwerpen
Not applicable
30
Antwerp
2025-06-01
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Antwerp, Genk, Namur
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Antwerp, Bruges, Brussels, Ghent, Hasselt, Leuven, Liège, Yvoir
2025-05-05
By invitation
Smith & Nephew, Inc.
Observational
170
Antwerp
2025-05-05
By invitation
Sinocare
Not applicable
70
Antwerp
2025-04-23
Active, closed
iOnctura
Phase 1/2
45
Antwerp, Roeselare
2025-04-22
Recruiting
University Hospital, Antwerp
Observational
500
Antwerp
2025-04-14
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Maastricht University
Not applicable
358
Brussels, Antwerp, Ghent, Liège, Yvoir, Hasselt, Jette, Kortrijk
2025-04-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Antwerp, Brussels, Ghent, Leuven
2025-03-31
Recruiting
Wissenschaftliches Institut Bethanien e.V
Observational
1,800
Antwerp, Leuven
2025-03-24
Recruiting
Bayer
Phase 1/2
450
Antwerp, Ghent, Leuven, Liège
2025-03-21
Active, closed
Immutep S.A.S.
Phase 3
756
Antwerp, Ghent, Namur
2025-03-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Antwerp, Genk, Ghent
2025-03-16
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
Aalst, Antwerp, Bruges
2025-03-10
Recruiting
Improving the Use of Immunotherapy to Treat Liver Cancer
NCT07623265Hepatocellular Carcinoma (HCC)
Universitaire Ziekenhuizen KU Leuven
Not applicable
300
Antwerp, Hasselt, Kortrijk, Roeselare
2025-03-04
Recruiting
Implementation and Evaluation of Nutrition Interventions
NCT06876272Healthy Participants, Nutrition Intervention, Higher Education Students
Vrije Universiteit Brussel
Not applicable
653
Antwerp, Diepenbeek, Leuven
2025-02-17
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Aalst, Antwerp, Boussu, Brasschaat, Bruges, Brussels, Charleroi, Genk
2025-02-12
Active, closed
The Rufaida Project: Researching the Impact of Ramadan Fasting on the Gut and Vaginal Microbiome
NCT07001358Intermittent Fasting, Gut Microbiome, Vaginal Microbiome
University Hospital, Antwerp
Observational
350
Antwerp
2025-02-04
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Antwerp, Leuven, Liège
2025-02-03
Recruiting
Sir Mortimer B. Davis - Jewish General Hospital
Observational
4,700
Antwerp
2025-02-01
Recruiting
Alimentiv Inc.
Not applicable
378
Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Edegem, Ghent, Leuven
2025-02-01
Not yet open
Radboud University Medical Center
Not applicable
380
Antwerp, Brussels, Brussles, Leuven, Sint-Niklaas
2025-02
By invitation
University Ghent
Not applicable
36
Antwerp, Ghent, Oudenaarde
2025-01-27
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Antwerp, Brasschaat, Bruges, Ghent, Leuven, Roeselare
2025-01-22
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Anderlecht, Antwerp
2025-01-15
Recruiting
Immunovant Sciences GmbH
Phase 2
240
Antwerp, Bruges, Brussels
2024-12-17
Recruiting
Jules Bordet Institute
Not applicable
284
Aalst, Antwerp, Bruges, Brussels, Genk, Ghent, Hasselt, Kortrijk
2024-12-10
Active, closed
ViiV Healthcare
Phase 3
326
Antwerp
2024-12-02
Active, closed
Daiichi Sankyo
Phase 3
700
Anderlecht, Antwerp, Bruges, Brussels, Leuven, Liège, Roeselare
2024-11-19
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
386
Aalst, Antwerp, Bonheiden, Bruges, Brussels, Ghent, Kortrijk, Leuven
2024-11-18
Recruiting
Salubris Biotherapeutics Inc
Phase 1/2
255
Antwerp, Brussels, Ghent, Yvoir
2024-10-23
Recruiting
Annemie Spooren
Not applicable
44
Antwerp, Ghent, Leuven
2024-10-09
Recruiting
University Hospital, Geneva
Not applicable
220
Antwerp
2024-10-01
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Antwerp, Brussels, Ghent, Leuven, Liège, Yvoir
2024-09-26
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Brasschaat, Herentals, Mechelen, Bruges, Roeselare, Antwerp
2024-09-16
Recruiting
Universiteit Antwerpen
Phase 2/3
90
Antwerp
2024-09-01
Recruiting
The TRICURE EU Pivotal Study
NCT06581471Tricuspid Valve Regurgitation, Heart Valve Disease, Cardiovascular Diseases
TRiCares
Not applicable
80
Aalst, Antwerp, Brussels, Liège, Roeselare
2024-08-29
Recruiting
Bayer
Phase 3
444
Antwerp, Leuven, Roeselare
2024-08-28
Recruiting
Universiteit Antwerpen
Not applicable
150
Antwerp
2024-08-27
Recruiting
University Hospital, Ghent
Not applicable
600
Antwerp, Brussels, Charleroi, Ghent, Liège, Roeselare, Saint-Servais
2024-08-24
Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
NCT06401356Hematologic Malignancy, Solid Tumor, Advanced Malignancies
DrugPelabresib
Novartis Pharmaceuticals
Phase 3
50
Antwerp, Bruges
2024-08-13
Recruiting
University Medical Center Groningen
Phase 3
300
Antwerp, Brussels, Leuven
2024-07-31
Recruiting
A Post-market Observational ORIGIN® CR Clinical Study
NCT05607966Total Knee Replacement
Symbios Orthopedie SA
Observational
199
Antwerp, Malle
2024-07-10
Recruiting
Multi-biomarkers in DEE
NCT07909382Developmental and Epileptic Encephalopathies (DEE)
Istituto Giannina Gaslini
Observational
200
Antwerp
2024-07-04
Recruiting
Anatomy-Based Fitting in Bimodal Cochlear Implant Users
NCT07691853Cochlear Implant, Sensorineural Hearing Loss, Hearing Aid
Universitair Ziekenhuis Brussel
Not applicable
25
Antwerp, Brussels
2024-07-01
Recruiting
IRCCS Sacro Cuore Don Calabria di Negrar
Not applicable
278
Antwerp
2024-06-28
Active, closed
Byondis B.V.
Phase 1
16
Antwerp, Leuven
2024-06-25
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Antwerp, Leuven, Liège, Roeselare, Yvoir
2024-06-03
Recruiting
Universiteit Antwerpen
Not applicable
270
Antwerp, Leuven
2024-05-26
Recruiting
CDR-Life AG
Phase 1
42
Antwerp, Brussels, Ghent
2024-05-24
Recruiting
University Hospital, Antwerp
Phase 3
174
Edegem, Aalst, Antwerp, Hasselt, Leuven
2024-05-24
Active, closed
Remote MS Care in Antwerp
NCT06179758Multiple Sclerosis
University Hospital, Antwerp
Not applicable
100
Edegem, Antwerp, Brasschaat
2024-05-23
Active, closed
University Hospital, Antwerp
Observational
300
Antwerp, Edegem
2024-05-22
Recruiting
Universiteit Antwerpen
Observational
100
Antwerp
2024-05-07
Active, closed
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections
NCT06945627Severe Mental Illness, Inflammation, Viral Infections, Mood Disorders
Sara Poletti
Observational
408,551
Antwerp
2024-05-02
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
Antwerp, Roeselare
2024-04-15
Recruiting
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
NCT06113913Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
DrugInfliximab
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Phase 4
275
Ghent, Ostend, Antwerp, Bonheiden, Bruges, Brussels, Genk, Leuven
2024-04-09
Recruiting
Universitaire Ziekenhuizen KU Leuven
Phase 2
53
Antwerp, Brussels, Ghent, Hasselt, Leuven
2024-04-08
Active, closed
Eli Lilly and Company
Phase 3
17,300
Antwerp, Bonheiden, Brasschaat, Brussels, Charleroi, Dendermonde, Edegem, Genk
2024-03-05
Recruiting
Cartilage Repair Systems BV
Observational
100
Ghent, Antwerp
2024-03-01
Recruiting
Takeda
Phase 3
50
Antwerp, Leuven
2024-03-01
Recruiting
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
2,000
Antwerp
2024-02-22
Active, closed
ViiV Healthcare
Phase 3
463
Brussels, Antwerp, Ghent
2024-02-21
Recruiting
Jules Bordet Institute
Not applicable
230
Antwerp, Edegem, Turnhout, Anderlecht, Auderghem, Brussels, Ghent, Sint-Niklaas
2024-02-07
Active, closed
Cochlear
Not applicable
46
Antwerp, Wommelgem
2024-02-05
Recruiting
AZ Sint-Jan AV
Phase 3
2,770
Aalst, Antwerp, Bonheiden, Bruges, Charleroi, Genk, Ghent, Hasselt
2024-01-29
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Antwerp
2023-12-31
Recruiting
Daiichi Sankyo
Phase 3
250
Anderlecht, Antwerp, Brussels, Leuven, Liège, Wilrijk
2023-12-30
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Yvoir, Ghent, Roeselare, Antwerp, Brussels
2023-12-28
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Aalst, Antwerp, Brussels, Leuven
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Antwerp, Auderghem, Bruges, Ghent, Kortrijk, Leuven, Mechelen, Ottignies
2023-12-21
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Antwerp, Ghent, Leuven
2023-12-20
Recruiting
Universiteit Antwerpen
Not applicable
150
Antwerp, Lier, Rumst, Wilrijk
2023-12-20
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Herentals, La Louvière, Ghent, Antwerp, Brussels
2023-12-12
Active, closed
BioNTech SE
Phase 1
41
Antwerp, Liège
2023-11-30
Active, closed
AstraZeneca
Phase 3
1,902
Antwerp, Brasschaat, Charleroi, Ghent, Leuven, Libramont-Chevigny
2023-11-14
Active, closed
AstraZeneca
Phase 3
863
Anderlecht, Antwerp, Ghent, Hasselt, Sint-Niklaas
2023-11-09
Recruiting
MaaT Pharma
Phase 2
387
Antwerp, Bruges, Brussels, Ghent, Leuven, Roeselare
2023-10-31
Recruiting
United Therapeutics
Phase 3
698
Aalst, Antwerp, Brussels, Ghent, Leuven, Liège
2023-10-30
Active, closed
AstraZeneca
Phase 3
895
Aalst, Antwerp, Ghent
2023-10-24
Active, closed
Cortex
Not applicable
400
Aalst, Antwerp, Genk
2023-10-23
Active, closed
Stichting European Myeloma Network
Phase 3
759
Anderlecht, Antwerp, Ghent, Leuven
2023-10-10
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Yvoir, Roeselare, Antwerp, Brussels
2023-09-18
Recruiting
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
NCT05569772Glucose Intolerance After a Recent History of Gestational Diabetes
DrugSemaglutide Injector
Universitaire Ziekenhuizen KU Leuven
Phase 3
252
Aalst, Antwerp, Bruges, Brussels, Ieper, Kortrijk, Leuven, Liège
2023-09-14
Active, closed
AnaptysBio, Inc.
Phase 2
420
Anderlecht, Liège, Leuven, Antwerp
2023-08-31
Recruiting
Universitair Ziekenhuis Brussel
Not applicable
75
Liège, Bruges, Antwerp, Ghent, Jette, Leuven
2023-08-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Leuven, Antwerp
2023-08-08
Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
NCT05985655Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC), Platinum-resistant High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers (HGSOC)
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Phase 1/2
230
Antwerp, Brussels, Liège
2023-07-06
Recruiting
Global Research Initiative for Patients Screening on MASH
NCT05651724MASH, MASLD, MASH With Fibrosis, Fibrosis, Liver
Julius Clinical
Observational
10,000
Brussels, Antwerp
2023-06-30
Recruiting
University Hospital, Antwerp
Phase 4
270
Brasschaat, Rumst, Ghent, Sint-Niklaas, Leuven, Charleroi, Antwerp, Brussels
2023-06-28
Recruiting
POS-ARI-ER Observational Study of Acute Respiratory Infections
NCT05814237Acute Respiratory Infection, Acute Respiratory Tract Infection
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
11,750
Antwerp, Brussels
2023-06-20
Recruiting
Robocath
Observational
500
Antwerp
2023-06-20
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
238
Antwerp, Bruges, Genk, Ghent, Leuven
2023-05-15
Active, closed
Gilead Sciences
Phase 3
654
Antwerp, Brasschaat, Brussels, Leuven, Namur
2023-05-08
Recruiting
Universiteit Antwerpen
Observational
90
Antwerp
2023-05-02
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Aalst, Antwerp, Arlon, Brussels, Dendermonde, Edegem, Herk-de-Stad, La Louvière
2023-04-11
Active, closed
Ebastine Versus Mebeverine in IBS Patients
NCT05815602IBS - Irritable Bowel Syndrome, IBS
DrugEbastine
Guy Boeckxstaens
Phase 3
200
Antwerp, Mechelen, Leuven, Bruges
2023-03-30
Recruiting
Liquid Biopsies in Esophageal Cancer
NCT05704530Esophageal Cancer
Universitaire Ziekenhuizen KU Leuven
Not applicable
248
Antwerp, Ghent, Leuven, Roeselare
2023-03-29
Recruiting
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
NCT05083247Pancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma
DrugsGemcitabine-nab-paclitaxel·MFOLFIRINOX
Erasme University Hospital
Phase 2
256
Antwerp, Brussels, Ghent, Kortrijk, La Louvière, Liège, Mons
2023-03-24
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Antwerp, Bruges, Ghent, Libramont-Chevigny, Roeselare, Sint-Niklaas, Wilrijk
2023-03-23
Recruiting
Takeda
Phase 3
160
Antwerp, Leuven
2023-03-06
Recruiting
Who Fares Best With Mindfulness Meditation
NCT05862636Healthy, Depression, Mental Health Issue
Prof. dr. Filip Raes
Observational
120
Antwerp, Deinze
2023-02-21
Active, closed
Sandoz
Observational
562
Aalst, Antwerp, Bonheiden, Brussels, Eeklo, Ghent, Herentals, Kortrijk
2023-02-16
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Antwerp, Ath, Bonheiden, Brussels, Dendermonde, Edegem, Kortrijk, La Louvière
2023-02-15
Active, closed
Genmab
Phase 3
900
Antwerp, Brussels, La Louvière, Liège, Yvoir, Ghent, Sint-Niklaas, Leuven
2023-02-08
Recruiting
Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery
NCT05084339Bariatric Surgery Status Complicating Pregnancy
Universitaire Ziekenhuizen KU Leuven
Observational
190
Aalst, Antwerp, Bonheiden, Bruges, Ghent, Kortrijk, Leuven
2023-01-25
Recruiting
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
NCT04436978Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation, Atrial Flutter
St. Antonius Hospital
Phase 4
2,000
Aalst, Antwerp, Bonheiden, Brussels, Genk, Ghent, Ieper, Kortrijk
2023-01-11
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Aalst, Antwerp, Bruges
2023-01-10
Active, closed
Janssen Research & Development, LLC
Phase 3
214
Antwerp
2022-12-15
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Antwerp, Brussels, Ghent, Leuven, Liège
2022-12-15
Active, closed
University Medical Center Groningen
Phase 3
1,750
Antwerp, Brussels, Hasselt, Kortrijk, Leuven, Ronse
2022-11-08
Active, closed
Bayer
Phase 1
284
Antwerp, Ghent
2022-11-04
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Anderlecht, Antwerp, Ghent, Haine Saint Paul La Louviere, Kortrijk, Leuven
2022-10-25
Active, closed
Bayer
Phase 1
129
Antwerp, Ghent, Leuven, Liège
2022-10-11
Active, closed
NEAT ID Foundation
Observational
500
Antwerp, Brussels
2022-10-10
Recruiting
Institute of Tropical Medicine, Belgium
Observational
345
Antwerp
2022-10-06
Recruiting
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
NCT05670301Autoinflammatory Disease, Autoimmune Diseases, Inflammation
University Hospital, Ghent
Not applicable
2,500
Antwerp, Brussels, Ghent, Hasselt
2022-09-28
Recruiting
Celgene
Phase 3
810
Genk, Ghent, Sint-Niklaas, Antwerp
2022-09-20
Recruiting
University of Ulm
Phase 3
650
Antwerp, Bruges, Brussels, Leuven, Roeselare, Yvoir
2022-09-13
Recruiting
Universitaire Ziekenhuizen KU Leuven
Phase 4
292
Antwerp, Edegem, Brussels, Jette, Tournai, Genk, Liège, Yvoir
2022-09-08
Active, closed
Exelixis
Phase 3
901
Antwerp, Brussels, Namur
2022-09-07
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Anderlecht, Yvoir, Aalst, Antwerp, Brussels, Leuven, Liège
2022-09-06
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Antwerp, Brasschaat, Brussels, Ghent, Kortrijk, Libramont, Liège, Wuerzburg
2022-08-17
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Antwerp, Bruges, Brussels, Ghent, Leuven, Liège, Mechelen, Roeselare
2022-07-22
Active, closed
Denali Therapeutics Inc.
Phase 2/3
65
Antwerp, Jette
2022-07-21
Active, closed
The TRICURE First in Human Trial
NCT05126030Tricuspid Regurgitation
TRiCares
Not applicable
20
Aalst, Antwerp, Brussels, Liège
2022-07-15
Recruiting
Nuvalent Inc.
Phase 1/2
840
Antwerp, Leuven
2022-06-09
Recruiting
Belgian Group of Digestive Oncology
Phase 2
134
Antwerp, Brussels, Liège, Bruges, Bonheiden, Charleroi, Ghent, Haine-Saint-Paul
2022-05-25
Recruiting
Universiteit Antwerpen
Observational
120
Antwerp, Ghent, Leuven, Bruges
2022-05-16
Active, closed
Pierre Fabre Medicament
Phase 3
815
Anderlecht, Antwerp, Brussels, Ghent, Merksem, Sint-Niklaas, Yvoir
2022-05-02
Recruiting
University College, London
Phase 3
1,042
Roeselare, Antwerp, Leuven, Namur
2022-04-14
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Antwerp, Ghent, Leuven
2022-04-11
Active, closed
Precise Procedural and PCI Plan (P4)
NCT05253677Coronary Artery Disease
CoreAalst BV
Not applicable
1,090
Jette, Aalst, Antwerp
2022-04-01
Recruiting
Anatomy-Based Fitting in Unexperienced Cochlear Implant Users
NCT05451628Cochlear Implants, Sensorineural Hearing Loss
Universitair Ziekenhuis Brussel
Not applicable
40
Brussels, Antwerp
2022-03-30
Active, closed
Pfizer
Phase 3
854
Anderlecht, Charleroi, Yvoir, Ghent, Antwerp, Brussels
2022-03-25
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Antwerp, Ghent, Leuven, Roeselare
2022-02-28
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2/3
286
Anderlecht, Edegem, Antwerp, Liège
2022-02-11
Active, closed
Denali Therapeutics Inc.
Phase 1/2
85
Antwerp, Leuven
2022-02-01
Recruiting
University Ghent
Observational
750
Ghent, Ottignies-Louvain-la-Neuve, De Haan, Roeselare, Antwerp
2022-01-11
Recruiting
University Hospital, Antwerp
Observational
550
Rumst, Sint-Niklaas, Leuven, Antwerp, Brasschaat, Edegem
2022-01-03
Active, closed
Abivax S.A.
Phase 2
203
Antwerp, Leuven
2021-12-03
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Genk, Yvoir, Kortrijk, Roeselare, Antwerp, Brasschaat, Bruges, Brussels
2021-11-23
Active, closed
European Association of Urology Research Foundation
Observational
1,076
Antwerp, Bruges, Ghent, Hasselt, Leuven
2021-11-19
Recruiting
Leiden University Medical Center
Phase 3
316
Antwerp, Brussels, Charleroi, Mons, Namur, Ostend
2021-11-11
Active, closed
argenx
Phase 2/3
15
Antwerp
2021-10-26
Recruiting
Belgian Registry on Coronary Function Testing
NCT06089031Coronary Microvascular Dysfunction, Coronary Artery Vasospasm
University Hospital, Antwerp
Observational
650
Deurne, Mechelen, Hasselt, Aalst, Antwerp, Bruges, Ieper, Kortrijk
2021-10-18
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Antwerp, Bruges, Ghent, Haine Saint Paul La Louviere, Kortrijk, Leuven, Roeselare
2021-10-14
Active, closed
Study of Lacutamab in Peripheral T-cell Lymphoma
NCT04984837Peripheral T Cell Lymphoma, Relapse/Recurrence
DrugsOxaliplatine·Gemcitabine
The Lymphoma Academic Research Organisation
Phase 2
49
Anderlecht, Antwerp, Bruges, Brussels, Charleroi, Edegem, Haine-Saint-Paul, Liège
2021-10-05
Recruiting
ContraBand™: Safety & Feasibility Study (RM-20-01)
NCT05230745Heart Failure, Left Sided
Restore Medical Ltd
Not applicable
55
Aalst, Antwerp, Genk
2021-09-28
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Antwerp, Brussels, Ghent
2021-09-22
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Antwerp, Bruges, Ghent, Leuven, Liège
2021-08-19
Active, closed
Dafne Balemans
Phase 4
736
Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Genk, Ghent, Lennik
2021-05-25
Active, closed
Incyte Corporation
Phase 3
654
Antwerp, Bruges, Brussels, Edegem, Ghent, Leuven, Liège, Roeselare
2021-04-15
Active, closed
Geron Corporation
Phase 3
327
Antwerp, Edegem, Haine-Saint-Paul, Ghent, Jette
2021-04-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Antwerp, Brussels, La Louvière, Leuven, Liège
2021-04-09
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Leuven, Ghent, Bruges, Antwerp
2021-03-11
Active, closed
Centre Hospitalier Universitaire de Liege
Not applicable
80
Liège, Antwerp, Woluwe-St. Lambert
2021-03-09
Active, closed
Metabotyping of Overweight and Obese Children
NCT04632511Metabolic Disease, Obesity, Infant
University Ghent
Not applicable
232
Ghent, Eeklo, Zottegem, Waregem, Antwerp, Bruges, Jette, Leuven
2021-02-15
Active, closed
Genmab
Phase 3
483
Antwerp, Bruges, Brussels, Ghent, Jette, La Louvière, Leuven, Sint-Niklaas
2021-01-13
Active, closed
Pfizer
Phase 3
841
Brussels, Charleroi, Kortrijk, Antwerp, Leuven, Liège, Wilrijk
2020-12-21
Active, closed
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
NCT04192747Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Stenosis
Elixir Medical Corporation
Not applicable
445
Antwerp, Bruges, Genk, Leuven
2020-12-16
Active, closed
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
NCT04225520Left Ventricular Dyssynchrony, Heart Failure, Cardiomyopathy, Dilated, Cardiac Remodeling, Ventricular
Universitaire Ziekenhuizen KU Leuven
Not applicable
500
Antwerp, Bruges, Ghent, Leuven, Ostend, Roeselare
2020-12-10
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Anderlecht, Antwerp, Assebroek, Bruges, Kortrijk, Roeselare
2020-12-07
Active, closed
Celyad Oncology SA
Phase 1
18
Antwerp, Brussels, Roeselare
2020-11-16
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Antwerp, Bruges, Ghent, Kortrijk
2020-11-12
Active, closed
Nyxoah S.A.
Not applicable
115
Antwerp
2020-10-14
Active, closed
Acerta Pharma BV
Phase 3
611
Antwerp, Bruges, La Louvière
2020-10-08
Active, closed
European Myeloma Network B.V.
Phase 3
302
Antwerp
2020-09-25
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Antwerp, Charleroi, Haine-St-Paul, Liège, Namur, Ottignies, Roeselare
2020-09-23
Active, closed
AbbVie
Phase 3
531
Antwerp, Brussels, La Louvière, Yvoir, Ghent, Leuven, Bruges
2020-09-10
Active, closed
AbbVie
Phase 3
330
Antwerp, Brussels, Charleroi, Ghent, Sint-Niklaas, Roeselare
2020-08-31
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Antwerp, Brussels, Liège
2020-08-25
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
240
Yvoir, Antwerp, Edegem, Ghent, Haine-Saint-Paul
2020-08-20
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Antwerp
2020-08-06
Recruiting
Doxapram Therapy in Preterm Infants (DOXA Trial)
NCT04430790Apnea of Prematurity, Respiratory Insufficiency
DrugDoxapram
Erasmus Medical Center
Phase 3
396
Brussels, Jette, Charleroi, Liège, Bruges, Antwerp, Leuven
2020-06-15
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Antwerp, Ghent, Leuven, Liège
2020-06-12
By invitation
University Hospital, Antwerp
Observational
150
Antwerp
2020-05-12
Active, closed
First in Men Study: BIOMAG-I
NCT04157153Coronary Artery Disease
Biotronik AG
Not applicable
116
Antwerp, Genk, Leuven
2020-04-27
Active, closed
Universitaire Ziekenhuizen KU Leuven
Observational
1,600
Leuven, Aalst, Antwerp, Arlon, Bonheiden, Bruges, Brussels, Charleroi
2020-03-12
Active, closed
KANDO Research
Not applicable
302
Antwerp, Aalst, Bonheiden, Dendermonde, Genk, Tienen
2020-02-18
Active, closed
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
NCT04089059Heart Failure NYHA Class III
Endotronix, Inc.
Not applicable
738
Aalst, Antwerp, Genk
2020-01-10
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Antwerp, Bruges, Brussels, Ghent, Haine-Saint-Paul, Hasselt, Leuven, Liège
2019-12-20
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Leuven, Antwerp, Ghent, Liège
2019-12-16
Active, closed
Neuspera Medical, Inc.
Not applicable
331
Antwerp
2019-12-13
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
140
Antwerp, Haine-Saint-Paul, Roeselare
2019-12-05
Recruiting
Conservative Endometrioma Surgery
NCT04151433Endometriosis Ovary, Endometrioma
Universitaire Ziekenhuizen KU Leuven
Not applicable
92
Antwerp, Brussels, Leuven, Liège
2019-10-24
Active, closed
Nyxoah S.A.
Not applicable
110
Antwerp
2019-09-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
150
Antwerp, Edegem, Leuven
2019-08-01
Recruiting
HighLife SAS
Not applicable
120
Antwerp, Bruges, Leuven
2019-05-28
Recruiting
Outcome Analysis in Septorhinoplasty
NCT03925389Rhinoplasty, Nasal Obstruction, Esthetics
FRANK DECLAU
Observational
750
Antwerp
2019-05-07
Active, closed
Javelin Medical
Not applicable
100
Aalst, Antwerp
2019-04-15
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Antwerp, Bruges, Brussels, Ghent, Haine-Saint-Paul, Hasselt, Leuven, Liège
2019-03-01
Active, closed
Follow-up in Gynecological Cancer Survivors
NCT03515993Gynecologic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,100
Antwerp, Ghent, Liège, Merksem
2019-02-21
Recruiting
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
NCT03852407Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome
DrugsPTCy·Thymoglobulin·Cyclophosphamid·Melphalan
University of Liege
Phase 2
114
Antwerp, Bruges, Brussels, Ghent, Leuven, Liège, Roeselare, Yvoir
2019-02-04
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
NCT03903835Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
DrugsXofigo·Cabazitaxel·Zytiga·Capivasertib
Karolinska Institutet
Phase 3
750
Aalst, Antwerp, Bruges, Genk, Ghent, Hasselt, Kortrijk, Liège
2019-02-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Aalst, Antwerp, Charleroi, Ghent, Liège, Merksem
2019-01-25
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
387
Antwerp, Brussels
2019-01-23
Active, closed
Amsterdam UMC, location VUmc
Not applicable
221
Antwerp, Genk, Leuven
2019-01-22
Active, closed
Celgene
Phase 3
363
Antwerp, Brasschaat, Brussels, Charleroi, Kortrijk, Leuven, Roeselare
2019-01-02
Recruiting
University of Liege
Observational
350
Antwerp, Brussels, Ghent, Leuven, Liège
2019-01-01
Recruiting
University Hospital, Antwerp
Not applicable
1,000
Brasschaat, Deurne, Edegem, Rumst, Sint-Niklaas, Antwerp
2018-11-05
Active, closed
V-Wave Ltd
Not applicable
605
Antwerp, Bruges
2018-09-19
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
109
Antwerp, Bruges, Leuven, Roeselare
2018-08-30
Recruiting
Belgian Central Sleep Apnea REgistry
NCT03621566Central Sleep Apnea
Universitaire Ziekenhuizen KU Leuven
Observational
1,500
Aalst, Antwerp, Bruges, Brussels, Ghent, Hasselt, Kortrijk, La Louvière
2018-06-25
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
61
Antwerp, Ghent, Leuven, Roeselare
2018-06-04
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
71
Antwerp, Bruges, Ghent, Leuven, Roeselare
2018-06-04
Recruiting
Jessa Hospital
Observational
70
Antwerp
2018-06-01
Active, closed
GlaxoSmithKline
Phase 2
237
Antwerp, Bruges, Leuven, Liège
2018-05-03
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Antwerp, Bruges, Brussels, Ghent, Kortrijk, Leuven, Mouscron
2018-04-27
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Anderlecht, Antwerp, Ghent, Hasselt, Leuven
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Aalst, Antwerp, Brussels, Charleroi, Ghent, Liège, Wilrijk, Yvoir
2018-03-23
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Aalst, Antwerp, Brussels, Ghent, Kortrijk, Liège
2018-03-02
Active, closed
ASPIRIN Trial Belgium
NCT03464305Colon Cancer
DrugAcetylsalicylic acid
University Hospital, Antwerp
Phase 3
148
Bornem, Brasschaat, Deurne, Edegem, Rumst, Sint-Niklaas, Antwerp, Bouge
2018-02-22
Active, closed
Marc Arbyn
Observational
500
Brussels, Ghent, Tienen, Antwerp, Liège
2017-12-29
Active, closed
DePuy Orthopaedics
Not applicable
400
Antwerp
2017-05-30
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Aalst, Antwerp, Brussels, Ghent, Haine-Saint-Paul, Leuven, Liège, Namur
2017-05-03
Active, closed
Acerta Pharma BV
Phase 3
635
Antwerp, Ghent, Leuven, Roeselare, Sint-Niklaas
2017-04-05
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Antwerp, Leuven
2017-03-07
Recruiting
Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
NCT04007783Benign or Malignant Tumour of the Oral Cavity, Stage III-IV Osteonecrosis, Mandibular Reconstruction, Fixed Dental Restoration
AZ Sint-Jan AV
Observational
80
Antwerp, Bruges, Leuven, Sint-Niklaas
2017-03-04
Active, closed
European Association of Urology Research Foundation
Observational
1,054
Antwerp, Ghent, Hasselt, Kortrijk, Leuven
2017-02-22
Active, closed
Acerta Pharma BV
Phase 3
310
Antwerp, Ghent, Roeselare, Yvoir
2017-02-02
Active, closed
Eisai Inc.
Phase 3
1,069
Aalst, Antwerp, Bonheiden, Brussels, Hasselt, Liège, Wilrijk
2016-10-13
Active, closed
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina
Shockwave Medical, Inc.
Observational
400
Antwerp, Genk
2016-03
Active, closed
Geron Corporation
Phase 2/3
289
Antwerp, Wilrijk, Bruges, Kortrijk, Brasschaat, Ghent, Leuven
2016-01-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Aalst, Antwerp, Bonheiden, Brussels, Haine Saint Paul La Louviere, Leuven, Liège, Namur
2015-11-19
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Antwerp
2015-05-01
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Leuven, Antwerp, Bruges, Liège
2015-03-05
Active, closed
ViiV Healthcare
Phase 3
371
Antwerp, Brussels
2015-02-23
Active, closed
Universitaire Ziekenhuizen KU Leuven
Not applicable
70
Antwerp, Ghent, Leuven
2015-01
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Antwerp, Brussels, Ghent, Gosselies, Leuven, Liège, Namur, Ottignies
2014-11-26
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Antwerp, Bruges, Brussels, Ghent, La Louvière, Roeselare
2014-11
Recruiting
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
NCT02595255Fertility Preservation, Lymphoma, Pediatrics Cancer, Gonadotropin-releasing Hormone Agonist
Erasme University Hospital
Observational
275
Montegnée, Antwerp, Brussels, Leuven, Liège
2014-04
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Antwerp, Bruges, Brussels, Ghent, Leuven, Yvoir
2013-09-09
Active, closed
Survivorship of Attune Primary Total Knee Prosthesis
NCT01754363Noninflammatory Degenerative Joint Disease
DePuy International
Not applicable
1,542
Antwerp
2013-02-01
Active, closed
Zwi Berneman
Phase 2
130
Antwerp, Brussels, Ghent, Liège, Roeselare, Yvoir
2012-10
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Antwerp, Brussels, Edegem, Haine-Saint-Paul, Leuven, Merksem, Namur, Ostend
2010-12
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
305
Antwerp
2009-09
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Antwerp, Brussels, Charleroi, Ghent, Leuven
2007-12
Recruiting
The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders
NCT07021404Suicidal Ideation, Suicide Attempt, Multicenter Study, Epidemiological Study
University Hospital, Ghent
Observational
50,000
Aalst, Antwerp, Bilzen, Bonheiden, Brasschaat, Bruges, Deinze, Dendermonde
2006-12-31
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Antwerp, Bruges, Brussels, Edegem, Ghent, Gosselies, Leuven
2004-09-15
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Antwerp, Brussels, Leuven, Liège, Seraing
2001-07-31
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
Antwerp, Bruges, Brussels, Edegem, Leuven, Mont-Godinne Yvoir, Ottignies
1998-10
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Antwerp, Brussels, Ghent
1994-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Antwerp, Bruges, Brussels, Edegem, Ghent, Leuven
1991-04-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
Antwerp, Bruges, Brussels, Brussels (Bruxelles), La Louvière, Leuven
1989-09
Rows per page Showing 1–290 of 290
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-belgium/city/antwerp

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,055 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 290 of those studies with a site in Antwerp.

How many clinical trials are recruiting in Antwerp?

150 of the 290 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 9 have not yet opened recruitment, 125 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Antwerp), 290 studies
PhaseStudiesRecruitingShare
Phase 31003634.5%
Not applicable684123.4%
Observational604120.7%
Phase 2301410.3%
Phase 1/21193.8%
Phase 4862.8%
Phase 2/3722.4%
Phase 1612.1%

Most active sponsors

Lead sponsors with the most studies (Antwerp)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC172
Universitaire Ziekenhuizen KU Leuven1713
University Hospital, Antwerp1611
Universiteit Antwerpen1211
Stichting Hemato-Oncologie voor Volwassenen Nederland104
European Organisation for Research and Treatment of Cancer - EORTC71
Eli Lilly and Company54
Regeneron Pharmaceuticals55
University Ghent53
AstraZeneca41
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.